[KROS] QoQ Quarter Result on 30-Jun-2023 [#Q2]

Stock
[KROS] Keros Therapeutics, Inc.
Announcement Date
07-Aug-2023
Financial Year
2023
Quarter
30-Jun-2023 [#Q2]
Profit Trend
QoQ- -14.56%
YoY- -57.56%
Quarter Report
KROS's Result
KROS's Financial Summary
View:
Show?
Quarter Result
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
Revenue 83 143 8 0 0 0 0 -
PBT -43,114 -40,243 -39,440 -37,505 -35,804 -29,718 -23,509 49.77%
Tax -277 3,812 -210 3,832 -3,065 2 -4,467 -84.30%
NP -43,114 -40,243 -39,440 -37,505 -32,739 -29,720 -19,042 72.34%
Tax Rate - - - - - - - -
Total Cost 43,197 40,386 39,448 37,505 32,739 29,720 19,042 72.56%
Ratio Analysis
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
NP Margin -51,944.58 -28,141.96 -493,000.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 CAGR
EPS -1.46 -1.34 -1.33 -1.27 -1.15 -1.09 -0.75 55.84%
EPS Diluted -1.46 -1.34 -1.33 -1.27 -1.15 -1.09 -0.75 55.84%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.